These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 10669645)

  • 41. Identification of oxidatively truncated ethanolamine phospholipids in retina and their generation from polyunsaturated phosphatidylethanolamines.
    Gugiu BG; Mesaros CA; Sun M; Gu X; Crabb JW; Salomon RG
    Chem Res Toxicol; 2006 Feb; 19(2):262-71. PubMed ID: 16485902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis.
    Sakata N; Uesugi N; Takebayashi S; Nagai R; Jono T; Horiuchi S; Takeya M; Itabe H; Takano T; Myint T; Taniguchi N
    Cardiovasc Res; 2001 Feb; 49(2):466-75. PubMed ID: 11164857
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Vitamin E oxidation in human atherosclerotic lesions.
    Terentis AC; Thomas SR; Burr JA; Liebler DC; Stocker R
    Circ Res; 2002 Feb; 90(3):333-9. PubMed ID: 11861423
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation.
    Hayek T; Fuhrman B; Vaya J; Rosenblat M; Belinky P; Coleman R; Elis A; Aviram M
    Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2744-52. PubMed ID: 9409251
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The role of advanced glycosylation end-products in the pathogenesis of atherosclerosis.
    Makita Z; Yanagisawa K; Kuwajima S; Bucala R; Vlassara H; Koike T
    Nephrol Dial Transplant; 1996; 11 Suppl 5():31-3. PubMed ID: 9044304
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Preparation and characterization of glucosylated aminoglycerophospholipids.
    Ravandi A; Kuksis A; Marai L; Myher JJ
    Lipids; 1995 Oct; 30(10):885-91. PubMed ID: 8538374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Non-enzymatic glycosylation of lipoproteins in the pathogenesis of atherosclerosis in diabetics].
    Calvo C
    Rev Med Chil; 1997 Apr; 125(4):460-5. PubMed ID: 9460289
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.
    Islam KN; O'Byrne D; Devaraj S; Palmer B; Grundy SM; Jialal I
    Atherosclerosis; 2000 May; 150(1):217-24. PubMed ID: 10781654
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Macrophage-derived foam cells freshly isolated from rabbit atherosclerotic lesions degrade modified lipoproteins, promote oxidation of low-density lipoproteins, and contain oxidation-specific lipid-protein adducts.
    Rosenfeld ME; Khoo JC; Miller E; Parthasarathy S; Palinski W; Witztum JL
    J Clin Invest; 1991 Jan; 87(1):90-9. PubMed ID: 1985115
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Licorice extract and its major polyphenol glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice.
    Fuhrman B; Buch S; Vaya J; Belinky PA; Coleman R; Hayek T; Aviram M
    Am J Clin Nutr; 1997 Aug; 66(2):267-75. PubMed ID: 9250104
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation.
    Babiy AV; Gebicki JM; Sullivan DR; Willey K
    Biochem Pharmacol; 1992 Mar; 43(5):995-1000. PubMed ID: 1554398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Chlorogenic acid inhibits non-enzymatic glycation and oxidation of low density lipoprotein].
    Cai R; Chen S; Jiang S
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):27-34. PubMed ID: 30146808
    [TBL] [Abstract][Full Text] [Related]  

  • 53. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oxidation of low-density lipoprotein with hypochlorite causes transformation of the lipoprotein into a high-uptake form for macrophages.
    Hazell LJ; Stocker R
    Biochem J; 1993 Feb; 290 ( Pt 1)(Pt 1):165-72. PubMed ID: 8439285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Influence of glycation on LDL-induced generation of fibrinolytic regulators in vascular endothelial cells.
    Zhang J; Ren S; Sun D; Shen GX
    Arterioscler Thromb Vasc Biol; 1998 Jul; 18(7):1140-8. PubMed ID: 9672075
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Oxidation of lipoproteins and atherosclerosis.
    Luc G; Fruchart JC
    Am J Clin Nutr; 1991 Jan; 53(1 Suppl):206S-209S. PubMed ID: 1985389
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oxidisability of low density lipoproteins in patients with carotid or femoral artery atherosclerosis.
    Andrews B; Burnand K; Paganga G; Browse N; Rice-Evans C; Sommerville K; Leake D; Taub N
    Atherosclerosis; 1995 Jan; 112(1):77-84. PubMed ID: 7772070
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glycation as an atherogenic modification of LDL.
    Younis N; Sharma R; Soran H; Charlton-Menys V; Elseweidy M; Durrington PN
    Curr Opin Lipidol; 2008 Aug; 19(4):378-84. PubMed ID: 18607185
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Serum lipoprotein and atherogenicity--relationship with particle size and composition of low density lipoproteins, and their modifications by oxidation and glycation].
    Takeuchi N; Saheki S
    Rinsho Byori; 1995 Aug; 43(8):753-62. PubMed ID: 7474432
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of troglitazone on in vitro oxidation of LDL and HDL induced by copper ions and endothelial cells.
    Cominacini L; Garbin U; Pastorino AM; Campagnola M; Fratta Pasini A; Davoli A; Rigoni A; Lo Cascio V
    Diabetologia; 1997 Feb; 40(2):165-72. PubMed ID: 9049476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.